drugset / Trial / NCT04716699

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

NCT04716699

NaSingle-groupOpen-labelBasic science

Summary

This clinical trial measures the amount and effect of lidocaine injected into patients with glioblastoma while they are undergoing surgical removal of their brain tumors. Lidocaine is a substance used to relieve pain by blocking signals at the nerve endings in skin. Information gained from this study may help researchers come up with new treatments to help patients with glioblastomas in the future.

Timeline

Start
2021-01-20
Primary completion
2021-12-26
Completion
2022-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications